Logo image
Back
Lung Cancer Screening in the United States, 2024: A National Health Interview Survey Analysis
Journal article   Peer reviewed

Lung Cancer Screening in the United States, 2024: A National Health Interview Survey Analysis

Elochukwu Ezenwankwo, Nicholas Yell and Jan M. Eberth
Chest, v 169(4), pp 1148-1153
01 Apr 2026
DOI: https://doi.org/10.1016/j.chest.2025.11.036
PMID: 41371489
Featured in Collection :   Drexel's Newest Publications
url
https://doi.org/10.1016/j.chest.2025.11.036View
Open Access via Drexel Libraries Read and Publish Program 2025 Restricted CC BY-NC-ND V4.0

Abstract

Consensus exists that asymptomatic, high-risk individuals should be offered annual low-dose CT screening for lung cancer (LC).1 In 2015, the National Health Interview Survey (NHIS) first reported low-dose CT screening among 4.5% of eligible individuals.2 These baseline data informed the target of 7.5% in Healthy People 2030,3 which also set a goal to reduce LC deaths to 25.1 per 100,000. Although data from the 2022 Behavioral Risk Factor Surveillance System indicate some improvement in uptake since 2015, overall prevalence remains low, between 16.4% and 18.1% nationally,4,5 with substantial variation across states. We used the newly released 2024 NHIS to provide updated estimates, offering critical insights for tracking progress and sustaining ongoing efforts to monitor and strengthen LC screening (LCS) implementation nationwide.

Metrics

10 Record Views

Details

Logo image